XBiotech (NASDAQ: XBIT) announced that it has successfully isolated and cloned an anti-Ebola product candidate using its True Human antibody ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE